FILE PHOTO: A injection pen of Novo Nordisk's weight-loss drug Wegovy is shown in this photo illustration in Oslo
Mounjaro, which uses the same active ingredient, was approved for diabetes patients last year, but some consumers were using it off-label for weight loss.Conagra might consider changing portion sizes of its snacks if the rising use of weight-loss drugs leads to a change in food consumption patterns. Hershey's CEO Michele Buck said the use of the drugs was not materially impacting the chocolate maker's business.
Abbott Laboratories, which makes glucose monitoring products, has said that the market was overestimating the impact to its sales from growing popularity of the drugs.
이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오: